Davie CA: A review of Parkinson's disease. Br Med Bull. 2008, 86: 109-127. 10.1093/bmb/ldn013.
Article
CAS
PubMed
Google Scholar
McKeith IG, Mosimann UP: Dementia with Lewy bodies and Parkinson's disease. Parkinsonism and Related Disorders. 2004, 10: S15-S18. 10.1016/j.parkreldis.2003.12.005.
Article
PubMed
Google Scholar
Adams JD, Odunze IN: Oxygen free radicals and Parkinson's disease. Free Radic Biol Med. 1991, 10: 161-169. 10.1016/0891-5849(91)90009-R.
Article
CAS
PubMed
Google Scholar
Olanow CW: A radical hypothesis for neurodegeneration. Trends Neurosci. 1993, 16: 439-444. 10.1016/0166-2236(93)90070-3.
Article
CAS
PubMed
Google Scholar
Schapira AH: Neuroprotection in PD - a role for dopamine agonists?. Neurology. 2003, 61: S34-S42.
Article
CAS
PubMed
Google Scholar
Jenner P: Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease. Curr Opin Neurol. 2003, 16: S3-S7. 10.1097/00019052-200312001-00002.
Article
CAS
PubMed
Google Scholar
Ferrari-Toninelli G, Bonini SA, Cenini G, Maccarinelli G, Grilli M, Uberti D, Memo M: Dopamine receptor agonists for protection and repair in Parkinson's disease. Curr Top Med Chem. 2008, 8: 1089-1099. 10.2174/156802608785161402.
Article
CAS
PubMed
Google Scholar
Radad K, Gille G, Rausch WD: Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Pharmacol Rep. 2005, 57 (6): 701-712.
CAS
PubMed
Google Scholar
Gassen M, Glinka Y, Pinchasi B, Youdim MB: Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur J Pharmacol. 1996, 308 (2): 219-225. 10.1016/0014-2999(96)00291-9.
Article
CAS
PubMed
Google Scholar
Kondo T, Ito T, Sugita Y: Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann NY Acad Sci. 1994, 738: 222-229.
Article
CAS
PubMed
Google Scholar
Ogawa N, Tanaka K, Asanuma M, Kawai M, Masumizu T, Kohno M, Mori A: Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Res. 1994, 657: 207-213. 10.1016/0006-8993(94)90969-5.
Article
CAS
PubMed
Google Scholar
Takashima H, Tsujihata M, Kishikawa M, Freed WJ: Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors. Exp Neurol. 1999, 159: 98-104. 10.1006/exnr.1999.7122.
Article
CAS
PubMed
Google Scholar
Ferger B, Teismann P, Mierau J: The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study. Brain Res. 2000, 883: 216-223. 10.1016/S0006-8993(00)02929-2.
Article
CAS
PubMed
Google Scholar
Uberti D, Carsana T, Francisconi S, Ferrari-Toninelli G, Canonico PL, Memo M: A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation. Biochem Pharmacol. 2004, 67: 1743-1750. 10.1016/j.bcp.2004.01.012.
Article
CAS
PubMed
Google Scholar
Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N: Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 1999, 838: 51-59. 10.1016/S0006-8993(99)01688-1.
Article
CAS
PubMed
Google Scholar
Tanaka K, Miyazaki I, Fujita N, Haque ME, Asanuma M, Ogawa N: Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist. Neurochem Res. 2001, 26: 31-36. 10.1023/A:1007672414239.
Article
CAS
PubMed
Google Scholar
Uberti D, Bianchi I, Olivari L, Ferrari-Toninelli G, Bonini SA, Memo M: Dopaminergic agonists: possibile neurorescue drugs endowed with independent and synergistic multisites of action. Neurochem Res. 2007, 32: 1726-1729. 10.1007/s11064-007-9350-9.
Article
CAS
PubMed
Google Scholar
Le WD, Jankovic J, Xie W, Appel SH: Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm. 2000, 107: 1165-73. 10.1007/s007020070030.
Article
CAS
PubMed
Google Scholar
Abramova NA, Cassarino DS, Khan SM, Painter TW, Bennett JP: Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. J Neurosci Res. 2002, 67: 494-500. 10.1002/jnr.10127.
Article
PubMed
Google Scholar
Fujita Y, Izawa Y, Ali N, Kanematsu Y, Tsuchiya K, Hamano S, Tamaki T, Yoshizumi M: Pramipexole protects against H2O2-induced PC12 cell death. Naunyn Schmiedebergs Arch Pharmacol. 2006, 372: 257-66. 10.1007/s00210-005-0025-2.
Article
CAS
PubMed
Google Scholar
Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Shapira AH, Jenner P: Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Exp Neurol. 2008, 212: 522-531. 10.1016/j.expneurol.2008.04.037.
Article
CAS
PubMed
Google Scholar
Uberti D, Bianchi I, Olivari L, Ferrari-Toninelli G, Canonico P, Memo M: Pramipexole prevents neurotoxicity induced by oligomers of beta-amyloid. Eur J Pharmacol. 2007, 569 (3): 194-196. 10.1016/j.ejphar.2007.05.009.
Article
CAS
PubMed
Google Scholar
Cassarino DS, Fall CP, Smith TS, Bennett JP: Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion. J Neurochem. 1998, 71: 295-301.
Article
CAS
PubMed
Google Scholar
Danzeisen R, Schwalenstoecker B, Gillardon F, Buerger E, Krzykalla V, Klinder K, Schild L, Hengerer B, Ludolph AC, Dorner-Ciossek C, Kussmaul L: Targeted antioxidant and neuroprotective properties of the dopamine agonist pramipexole and ist nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-L-propylamino-benzathiazole Dihydrochloride]. J Pharmacol Exp Ther. 2006, 316: 189-199. 10.1124/jpet.105.092312.
Article
CAS
PubMed
Google Scholar
Sayeed I, Parvez S, Winkler-Stuck K, Seitz G, Trieu I, Wallesch CW, Schönfeld P, Siemen D: Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole. FASEB J. 2006, 20 (3): 556-8.
CAS
PubMed
Google Scholar
Gribkoff VK, Bozik ME: KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzohiazole-diamine dihydrochloride monohydrate] for the treatment of Amyotrphic Lateral Sclerosis. CNS Neuroscience & Ther. 2008, 14: 215-226. 10.1111/j.1755-5949.2008.00048.x.
Article
CAS
Google Scholar
Gu M, Iravani M, Cooper JM, Jenner P, Shapira AHV: Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J Neurochem. 2004, 91: 1075-1081. 10.1111/j.1471-4159.2004.02804.x.
Article
CAS
PubMed
Google Scholar
Koopman WJH, Verkaart S, van Emst-de Vries SE, Grefte S, Smeitink JAM, Willems PHGM: Simultaneous quantification of oxidative stress and cell spreading using 5-(and 6-)-chloromethyl-2'-7'-dichlorofluorescein. Cytometry Part A. 2006, 69A: 1184-1192. 10.1002/cyto.a.20348.
Article
CAS
Google Scholar
Gomes A, Fernandes E, Lima JLFC: Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods. 2005, 65: 45-80. 10.1016/j.jbbm.2005.10.003.
Article
CAS
PubMed
Google Scholar
Swift LM, Sarvazyan N: Localization of dichlorofluorescein in cardiac myocytes: Implications for assessment of oxidative stress. Am J Physiol Heart Circ Physiol. 2000, 278: H982-H990.
PubMed Central
CAS
PubMed
Google Scholar